Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M	Ben Fidler	05/24/19	National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More	Alex Lash	05/24/19	National
Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs	Frank Vinluan	05/23/19	San Francisco
Agrilyst Rebrands as Artemis, Lands $8M for Indoor Farming Software	Frank Vinluan	05/22/19	New York
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection	Frank Vinluan	05/22/19	Texas
AI Startup Clinc Snags $52M Series B to Expand Offices, Markets	Sarah Schmid Stevenson	05/21/19	Detroit Ann Arbor
Sebastian Thrun and Udacity Launch New Self-Driving Nanodegree	Bernadette Tansey	05/21/19	San Francisco
Merck Preempts Peloton Therapeutics IPO With $1B Acquisition Deal	Frank Vinluan	05/21/19	New York
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms	Ben Fidler	05/20/19	New York
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More	Frank Vinluan	05/17/19	National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight	Ben Fidler	05/16/19	National
BioClarity, Maker of “Clean, Green” Skincare Products, Raises $13M	Sarah de Crescenzo	05/16/19	San Diego
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September	Corie Lok	05/16/19	Boston
Karat Gets $28M for Software, Team That Assess Job-Seeking Engineers	Jeff Buchanan	05/15/19	Seattle
Endpoint Security Company CrowdStrike Files Publicly for IPO	Bernadette Tansey	05/14/19	San Francisco
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups	Frank Vinluan	05/13/19	Boston
Milestones of Innovation 17: ‘Golden Spike’ Heralds Era of Cheap Steel	Victor McElheny	05/10/19	National
Tech Ethics, Regulation & Strategy: Here’s the Napa Summit Agenda	Gregory T. Huang	05/10/19	National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More	Ben Fidler	05/10/19	National
Uber Completes $8.1B Public Market Debut in Spite of Tumultuous Past	Bernadette Tansey	05/09/19	San Francisco
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials	Frank Vinluan	05/09/19	National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting	Ben Fidler	05/07/19	National
Flexe Gets $43M to Expand On-demand Warehousing and Fulfillment Tools	Jeff Buchanan	05/07/19	Seattle
Canadian VCs Lead US in Gender Parity, But Both Need Work: Report	Angela Shah	05/07/19	National
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea	Ben Fidler	05/06/19	New York
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More	Alex Lash	05/03/19	National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments	Frank Vinluan	05/03/19	National
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan	David Holley	05/02/19	Texas
Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream	Frank Vinluan	05/02/19	National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?	Ben Fidler	05/02/19	National
Page 1 of 286	next page »